Par Drugs and Chemicals (NSE:PAR) EV-to-EBITDA : 10.83 (As of May. 30, 2024)

Par Drugs and Chemicals EV-to-EBITDA Chart

Par Drugs and Chemicals Quarterly Data
	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-EBITDA	Get a 7-Day Free Trial															8.13	13.84	11.38	11.84	9.92

Competitive Comparison of Par Drugs and Chemicals's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Par Drugs and Chemicals's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Par Drugs and Chemicals's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Par Drugs and Chemicals's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Par Drugs and Chemicals's EV-to-EBITDA falls into.

Par Drugs and Chemicals EV-to-EBITDA Calculation

Par Drugs and Chemicals's EV-to-EBITDA for today is calculated as:

Par Drugs and Chemicals's current Enterprise Value is ₹2,498.0 Mil.
Par Drugs and Chemicals's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹230.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Par Drugs and Chemicals  (NSE:PAR) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Par Drugs and Chemicals's PE Ratio for today is calculated as:

Par Drugs and Chemicals's share price for today is ₹232.80.
Par Drugs and Chemicals's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹11.780.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Par Drugs and Chemicals EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Par Drugs and Chemicals's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Par Drugs and Chemicals (NSE:PAR) Business Description